Sodium iodide symporter-based strategies for diagnosis and treatment of thyroidal and nonthyroidal malignancies

Thyroid

Volumn 11, Issue 9, 2001, Pages 839-847

  Heufelder, Armin E ^a   Morgenthaler, Nils ^b   Schipper, Meike L ^a   Joba, Werner ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Brahms Diagnostica   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GENE PRODUCT; IODIDE; RADIOACTIVE IODINE; SODIUM IODIDE; SODIUM IODIDE SYMPORTER; UNCLASSIFIED DRUG;

BENIGN TUMOR; BREAST CANCER; CONFERENCE PAPER; CYTOKINE PRODUCTION; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADIOISOTOPE DIAGNOSIS; THYROID CANCER;

ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; MALE; PROSTATIC NEOPLASMS; SYMPORTERS; THYROID GLAND; THYROID NEOPLASMS;

EID: 0034858133     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072501316973091     Document Type: Review

References (98)

1. Iodide transport in the thyroid gland
2. Expression of pendrin and the pendred syndrome (PDS) gene in human thyroid tissues
3. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS)
4. Pendred’s syndrome: Identification of the genetic defect a century after its recognition
5. The Pendred syndrome gene encodes a chloride-iodide transport protein
6. Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells
7. Cloning and characterization of the thyroid iodide transporter
8. Cloning of the human sodium iodide symporter
9. Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter
10. Cloning of the human sodium-iodide symporter promoter and characterization in a differentiated human thyroid cell line, KAT-50
11. Cloning of a functional promoter of the human sodium/iodide symporter gene
12. I− symporter
13. The paired-domain transcription factor Pax-8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic AMP-dependent transcription
14. Regulation of thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells
15. I− symporter in cultured human thyroid cells exposed to thyrotropin and in Graves’ thyroid tissue
16. I− symporter gene expression in rat thyroid FRTL-5 cells
17. Resting human female breast tissue produces iodinated proteins
18. Iodoprotein formation by rat mammary glands during pregnancy and early postpartum period
19. Characteristics of the prolactin stimulation of iodide uptake into mouse mammary gland explants
20. Effect of prolactin on sodium iodide symporter expression in mouse mammary gland explants
21. Autoregulation of thyroid-specific gene transcription by thyroglobulin
22. Follicular thyroglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide symporter gene
23. Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells
24. I− symporter messenger RNA and protein levels in FRTL-5 rat thyroid cells
25. I− symporter messenger ribonucleic acid levels in FRTL-5 cells
26. Hypothyroidism in transgenic mice expressing IFNγ, in the thyroid
27. Regulation and tissue distribution of the human sodium iodide symporter gene
28. The sodium iodide symporter gene and its regulation by cytokines found in autoimmunity
29. Regulation of sodium-iodide symporter gene expression in FRTL-5 rat thyroid cells
30. I− symporter with an anti-COOH terminus antibody
31. Monoclonal antibodies against the human sodium iodide symporter: Utility for immunocytochemistry of thyroid cancer
32. Development of monoclonal antibodies against the human sodium iodide symporter: Immunohistochemical characterization of this protein in thyroid cells
33. I− symporter distribution in human thyroid tissues: An immunohistochemical study
34. Characterization of autonomous thyroid adenoma: Metabolism, gene expression and pathology
35. I− symporter gene in human thyroid tumors: A comparison study with other thyroid-specific genes
36. Analysis of human sodium/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases
37. Iodide symporter gene expression in normal and transformed rat thyroid cells
38. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas
39. Iodide symporter gene expression in human thyroid tumors
40. Sodium-iodide symporter (NIS) expression in lymph node metastases of papillary thyroid carcinomas
41. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells
42. Redifferentiation therapy with retinoids: Therapeutic options for advanced follicular and papillary thyroid carcinoma
43. I− symporter gene methylation status
44. I− symporter in human thyroid tissues and salivary gland tissues
45. Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands
46. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa
47. I− symporter distribution in human extra-thyroidal tissues
48. Biological evidence for extrathyroidal thyroxine formation
49. Salivary and lacrimal gland involvement in a patient who undergone a thyroidectomy and was treated with radioiodine for thyroid cancer
50. Patterns of radioiodine uptake by the lactating breast
51. Radioiodine breast uptake in nonbreastfeeding women: Clinical and scintigraphic characteristics
52. Tissue iodine content and serum-mediated 125I uptake-blocking activity in breast cancer
53. Retinoid acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line
54. Susceptibility of Candida albicans to peroxidase-catalyzed oxidation products of thiocyanate, iodide and bromide
55. Environmental iodine deficiency: A challenge to the evolution of terrestrial life?
56. Radioiodine uptake by squamous-cell carcinoma of the lung
57. Iodine 131 uptake in a pleuropericardial cyst: Case report of a false-positive radioiodine total body scan result in a patient with a thyroid cancer
58. Whole-body scintigraphy with radioiodine-131. A comprehensive list of false-positives with some examples
59. Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer
60. I− symporter gene
61. Expression of sodium iodide symporter in metastatic and follicular human thyroid tissues
62. Reestablishment of in vitro and in vivo iodide uptake by transfection of the human sodium iodide symporter (hNIS) in a hNIS defective human thyroid carcinoma cell line
63. I− symporter in human glioma cells by adenovirus-mediated gene delivery
64. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene
65. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy
66. I− symporters for radioiodine concentrator gene therapy
67. Increased I-131 uptake in local recurrence and distant metastases after second treatment with retinoid acid
68. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines
69. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter
70. Iodine metabolism and thyroid physiology: Current concepts
71. Mammary gland dysplasia in iodine deficiency
72. Suppressive effect of iodine on DMBA induced breast tumour growth in the rat
73. Iodine and mammary cancer
74. Role of iodine in evolution and carcinogenesis of thyroid, breast and stomach
75. Hypothesis: Iodine, selenium and the development of breast cancer
76. The mammary gland iodide transporter is expressed during lactation and in breast cancer
77. I− symporter (NIS) antibody with iodide uptake inhibiting activity in autoimmume thyroid diseases
78. 99mTc-Pertechnetate scintigraphy as an aid in the diagnosis of breast masses
79. Regulation of the sodium/iodide-symporter by retinoids - A review
80. Circulating tumor markers in breast cancer: Accepted utilities and novel prospects
81. Postoperative follow-up of breast cancer patients: Overview and progress in the use of tumor markers
82. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma
83. Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium iodide symporter messenger ribonucleic acid transcripts in peripheral blood
84. HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis
85. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
86. Predictive value of estrogen receptors evaluated by quantitative immunohistochemical analysis in breast cancer
87. Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment
88. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers
89. Routinely available indicators of prognosis in breast cancer
90. Human breast uptake of radioactive iodine
91. The role of ultrasound in breast cancer screening. A consensus statement by the European Group for Breast Cancer Screening
92. Role and evaluation of mammography and other imaging methods for breast cancer detection, diagnosis, and staging
93. Ten-year risk of false positive screening mammograms and clinical breast examinations
94. Cancer statistics, 1998
95. Breast cancer imaging with radiolabeled antibodies
96. 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis
97. Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma
98. The molecular biology of breast cancer: Accelerating clinical applications